Related Experiment Video

Updated: Aug 10, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Central diabetes insipidus preceding acute myeloid leukemia with t(3;12)(q26;p12)

P Nieboer1, E Vellenga, R Adriaanse

  • 1Department of Internal Medicine, University Hospital Groningen, The Netherlands. p.nieboer@int.azg.nl

The Netherlands Journal of Medicine
|March 11, 2000
PubMed

Insights

Central diabetes insipidus (DI) can be an early indicator of acute myeloid leukemia (AML). This case highlights a rare association between AML with a t(3;12) translocation and DI.

Area of Science:

  • Hematology
  • Endocrinology

Background:

  • Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy.
  • Central diabetes insipidus (DI) is characterized by inadequate antidiuretic hormone secretion.

Observation:

  • A 52-year-old woman presented with polyuria and polydipsia, indicative of central DI.
  • The central DI was the initial clinical manifestation of AML.

Findings:

  • Cytogenetic analysis revealed a novel balanced translocation, t(3;12)(q26;p12), in the AML cells.
  • The patient experienced disease relapse and deep venous thrombosis despite initial chemotherapy and vasopressin treatment.

Implications:

  • This case represents the first reported association between AML with the t(3;12) translocation and central DI.
  • Understanding the pathogenesis of DI in AML is crucial for early diagnosis and management.
  • Further research into rare AML-DI associations may reveal new diagnostic and therapeutic strategies.

More Related Videos

Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice10:02

Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice

Published on: January 6, 2023

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...